Protective trend of anti-androgen therapy during the COVID-19 pandemic: A meta-analysis

DOI record: { "DOI": "10.1016/j.jinf.2022.03.020", "ISSN": [ "0163-4453" ], "URL": "http://dx.doi.org/10.1016/j.jinf.2022.03.020", "alternative-id": [ "S016344532200175X" ], "author": [ { "ORCID": "http://orcid.org/0000-0002-4622-833X", "affiliation": [], "authenticated-orcid": false, "family": "Meng", "given": "Jialin", "sequence": "first" }, { "affiliation": [], "family": "Ge", "given": "Qintao", "sequence": "additional" }, { "affiliation": [], "family": "Li", "given": "Jiawei", "sequence": "additional" }, { "affiliation": [], "family": "Lu", "given": "Xiaofan", "sequence": "additional" }, { "affiliation": [], "family": "Chen", "given": "Yonghao", "sequence": "additional" }, { "affiliation": [], "family": "Wang", "given": "Haitao", "sequence": "additional" }, { "affiliation": [], "family": "Zhang", "given": "Meng", "sequence": "additional" }, { "affiliation": [], "family": "Du", "given": "Juan", "sequence": "additional" }, { "affiliation": [], "family": "Zhang", "given": "Li", "sequence": "additional" }, { "affiliation": [], "family": "Hao", "given": "Zongyao", "sequence": "additional" }, { "affiliation": [], "family": "Liang", "given": "Chaozhao", "sequence": "additional" } ], "container-title": [ "Journal of Infection" ], "content-domain": { "crossmark-restriction": false, "domain": [] }, "created": { "date-parts": [ [ 2022, 3, 24 ] ], "date-time": "2022-03-24T23:24:56Z", "timestamp": 1648164296000 }, "deposited": { "date-parts": [ [ 2022, 4, 2 ] ], "date-time": "2022-04-02T20:08:38Z", "timestamp": 1648930118000 }, "funder": [ { "DOI": "10.13039/501100001809", "doi-asserted-by": "publisher", "name": "National Natural Science Foundation of China" } ], "indexed": { "date-parts": [ [ 2022, 4, 4 ] ], "date-time": "2022-04-04T13:35:16Z", "timestamp": 1649079316065 }, "is-referenced-by-count": 0, "issn-type": [ { "type": "print", "value": "0163-4453" } ], "issued": { "date-parts": [ [ 2022, 3 ] ] }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2022, 3, 1 ] ], "date-time": "2022-03-01T00:00:00Z", "timestamp": 1646092800000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S016344532200175X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S016344532200175X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "prefix": "10.1016", "published": { "date-parts": [ [ 2022, 3 ] ] }, "published-print": { "date-parts": [ [ 2022, 3 ] ] }, "publisher": "Elsevier BV", "reference": [ { "DOI": "10.1111/andr.12167", "article-title": "Androgen receptor-related diseases: what do we know?", "author": "Shukla", "doi-asserted-by": "crossref", "first-page": "366", "issue": "3", "journal-title": "Andrology", "key": "10.1016/j.jinf.2022.03.020_bib0001", "volume": "4", "year": "2016" }, { "DOI": "10.1007/s40257-019-00493-z", "article-title": "Topical antiandrogen therapies for androgenetic alopecia and acne vulgaris", "author": "Marks", "doi-asserted-by": "crossref", "first-page": "245", "issue": "2", "journal-title": "Am J Clin Dermatol", "key": "10.1016/j.jinf.2022.03.020_bib0002", "volume": "21", "year": "2020" }, { "DOI": "10.1016/j.annonc.2020.04.479", "article-title": "Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532)", "author": "Montopoli", "doi-asserted-by": "crossref", "first-page": "1040", "issue": "8", "journal-title": "Ann Oncol", "key": "10.1016/j.jinf.2022.03.020_bib0003", "volume": "31", "year": "2020" }, { "DOI": "10.1097/JU.0000000000002180", "article-title": "5alpha-reductase inhibitors are associated with reduced risk of SARS-CoV-2 infection: a matched-pair, registry-based analysis", "author": "Lyon", "doi-asserted-by": "crossref", "first-page": "183", "issue": "1", "journal-title": "J Urol", "key": "10.1016/j.jinf.2022.03.020_bib0004", "volume": "207", "year": "2022" }, { "article-title": "Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2", "author": "Qiao", "journal-title": "Proc Natl Acad Sci U S A.", "key": "10.1016/j.jinf.2022.03.020_bib0005", "year": "2020" }, { "DOI": "10.1038/s41467-021-24342-y", "article-title": "The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells", "author": "Leach", "doi-asserted-by": "crossref", "first-page": "4068", "issue": "1", "journal-title": "Nat Commun", "key": "10.1016/j.jinf.2022.03.020_bib0006", "volume": "12", "year": "2021" }, { "DOI": "10.1016/j.isci.2021.102254", "article-title": "Targeting androgen regulation of TMPRSS2 and ACE2 as a therapeutic strategy to combat COVID-19", "author": "Deng", "doi-asserted-by": "crossref", "issue": "3", "journal-title": "iScience", "key": "10.1016/j.jinf.2022.03.020_bib0007", "volume": "24", "year": "2021" }, { "DOI": "10.1016/j.eururo.2021.12.013", "article-title": "A phase 2 trial of the effect of antiandrogen therapy on COVID-19 Outcome: No evidence of benefit, supported by epidemiology and in vitro data", "author": "Welen", "doi-asserted-by": "crossref", "first-page": "285", "issue": "3", "journal-title": "Eur Urol", "key": "10.1016/j.jinf.2022.03.020_bib0008", "volume": "81", "year": "2022" } ], "reference-count": 8, "references-count": 8, "relation": {}, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S016344532200175X" } }, "score": 1, "short-container-title": [ "Journal of Infection" ], "short-title": [], "source": "Crossref", "subject": [ "Infectious Diseases", "Microbiology (medical)" ], "subtitle": [], "title": [ "Protective trend of anti-androgen therapy during the COVID-19 pandemic: A meta-analysis" ], "type": "journal-article" }